- Investing Ideas
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
BioGaia
Market Cap: SEK 11.6b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 114.70
7D
1.4%
1Y
16.2%
Vitrolife
Market Cap: SEK 12.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 91.80
7D
-0.05%
1Y
-32.5%
Camurus
Market Cap: SEK 37.5b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 630.00
7D
-0.7%
1Y
-8.9%
AddLife
Market Cap: SEK 19.6b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 160.50
7D
1.8%
1Y
-7.0%
Bonesupport Holding
Market Cap: SEK 15.0b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 228.00
7D
1.6%
1Y
-20.7%
BioArctic
Market Cap: SEK 29.9b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 337.20
7D
3.1%
1Y
41.2%
Swedish Orphan Biovitrum
Market Cap: SEK 160.2b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 461.40
7D
2.9%
1Y
61.3%